John R. Schmelzer

CYP4F2 genetic variant alters required warfarin dose

Michael D. Caldwell, Tarif Awad, Julie A. Johnson et al. · Blood · 2008 · 519 citations · Full text

A Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data

Michael A Hillman, Russell A. Wilke, Steven H. Yale et al. · Clinical Medicine & Research · 2005 · 196 citations · Full text

Evaluation of Genetic Factors for Warfarin Dose Prediction

Michael D. Caldwell, Richard L. Berg, K. Q. Zhang et al. · Clinical Medicine & Research · 2007 · 154 citations · Full text

A randomized controlled trial of genotype-based Coumadin initiation

James K. Burmester, Richard L. Berg, Steven H. Yale et al. · Genetics in Medicine · 2011 · 123 citations · Full text

Clinical Trials, Genotype-based Coumadin Initiation, Therapeutic Efficacy +4

Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism

Margaret C. Fang, Dongjie Fan, Sue Hee Sung et al. · Medical Care · 2016 · 122 citations · Full text